MESOBLAST LIMITED
Who is MESOBLAST LIMITED?
Mesoblast (ASX:MSB; Nasdaq:MESO) is developing and commercializing allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases with significant, unmet medical needs. The Company's Phase 3 off-the-shelf mesenchymal lineage cell product candidates are: • RYONCIL™ (remes...See more
Industry & Specialities
Others
Countries of Operation
Australia Singapore
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
51-200 Employees
Year Founded:
2004 (22 years)
Address:
LEVEL 38, 55 COLLINS ST; MELBOURNE, VIC 3000, AU
Employees by Department
Key Decision Makers
Andrew Chaponnel
Interim CFO
Normand Davidzon
Vice President, Engineering Technology
Dina Pratt
Head Of Human Resources (Global)
Insight
Signals
At a glance- Operates in multiple countries
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
2employees
Senior
6employees
Non-managers
12employees
Financials
HIGH
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has MESOBLAST LIMITED been operating for?
- What is the funding status of MESOBLAST LIMITED?
- Where is MESOBLAST LIMITED's headquarter?
- What MESOBLAST LIMITED's spending power?
- Does MESOBLAST LIMITED have a presence in the domain it operates in?